DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Surgical Oncology"
DOI: 10.1186/s12957-020-01953-1
Abstract: Background Deoxycytidine kinase ( DCK ), an enzyme in the nucleoside biosynthetic pathway, can affect the development of immune cells. However, the relationships between the expression of DCK , patient prognosis, and tumor-infiltrating immune cells… read more here.
Keywords: hepatocellular carcinoma; dck expression; expression dck; dck ... See more keywords